Results 71 to 80 of about 218,532 (303)

Progression of extrapyramidal signs in Alzheimer's disease. clinical and neuropathological correlates [PDF]

, 2015
Extrapyramidal signs (EPS) are frequent in Alzheimer's disease (AD) and core manifestation of related diseases, i.e., dementia with Lewy bodies and Parkinson's disease; furthermore, Lewy bodies and AD-type pathology occur in all three ...
Bruno, Giuseppe, Hawes, Stephen E, Mayeux, Richard, Monsell, Sarah E, Tosto, Giuseppe   +4 more
core   +1 more source

Progressive Neuropsychiatric Symptoms and Motor Impairment [PDF]

JAMA Neurology, 2014
A 42-year-old white man presented with cognitive impairment and behavioral changes followed by rapidly progressive motor and gait impairment. Magnetic resonance imaging revealed striking multifocal white matter signal change, areas of restricted diffusion, diffuse callosal signal change, and atrophy and hyperintensity of the corticospinal tracts.
Mahtab, Ghadiri, Michael E, Buckland, Ian J, Sutton, Suad, Al Jahdhami, Simon, Flanagan, Robert, Heard, Yael, Barnett, Jeffrey, Brennan, Michael H, Barnett   +8 more
openaire   +2 more sources

Effectiveness of rTMS on Working Memory and Inhibitory Impairments in Patients With Post‐Stroke Executive Deficits

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Considerable efforts have been dedicated to developing effective treatments for post‐stroke executive impairment (PSEI), among which repetitive transcranial magnetic stimulation (rTMS) has shown great potential. This study aimed to investigate the therapeutic effects of high‐frequency rTMS on working memory (WM) and response ...
Mengting Lao, Rongwei Du, Zhujun Wang, Yang Gao, Meiling Cheng, Xianglong Wang, Wen Wu   +6 more
wiley   +1 more source

Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome.

PLoS ONE, 2018
BackgroundNeuropsychiatric symptoms and reduced health-related quality of life (HRQoL) are frequent in multiple sclerosis, where are associated with structural brain changes, but have been less studied in clinically isolated syndrome (CIS).ObjectiveTo ...
Eva Hyncicova, Adam Kalina, Martin Vyhnalek, Tomas Nikolai, Lukas Martinkovic, Jiri Lisy, Jakub Hort, Eva Meluzinova, Jan Laczó   +8 more
doaj   +1 more source

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial [PDF]

, 2014
David R Coghill,1 Tobias Banaschewski,2 Michel Lecendreux,3 César Soutullo,4 Alessandro Zuddas,5 Ben Adeyi,6 Shaw Sorooshian7 1Division of Neuroscience, University of Dundee, Dundee, UK; 2Child and Adolescent Psychiatry and Psychotherapy, Central
Alessandro Alessandro Zuddas, Ben Adeyi, Cesar Soutullo, David Coghill, Katharine Murkett, Michel Lecendreux, Shaw Sorooshian, Tobias Banaschewski   +7 more
core   +6 more sources

Poststroke Neuropsychiatric Symptoms and Pseudoseizures [PDF]

The Primary Care Companion For CNS Disorders, 2003
LESSONS LEARNED AT THE INTERFACE OF MEDICINE AND PSYCHIATRY: The Psychiatric Consultation Service at Massachusetts General Hospital (MGH) sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. Such consultations require the integration of medical and psychiatric knowledge. During their thrice-weekly rounds, Dr.
Jeff C., Huffman, Theodore A., Stern
openaire   +2 more sources

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich, Jonathan A. Gernert, Hanna Zimmermann, Lisa Tagnin, Marianthi Zeinaki, Laura Sanzo, Letizia Vogler, Elisabeth Kaufmann, Justina Dargvainiene, Frank Leypoldt, Gérard N. Bischof, Robert Perneczky, Boris‐Stephan Rauchmann, Simon Lindner, Günter U. Höglinger, Rudolf A. Werner, Martin Kerschensteiner, Tania Kümpfel, Matthias Brendel, Franziska S. Thaler   +19 more
wiley   +1 more source

Neuropsychiatric symptoms and their impact on quality of life among patients with multiple sclerosis

Indian Journal of Psychiatry
Background: Neuropsychiatric symptoms in multiple sclerosis (MS) are common, often unrecognized. These symptoms often increase morbidity and lead to poor quality of life (QOL).
Prakrithi Shivaprakash, Sundarnag Ganjekar, M Netravathi, Geetha Desai   +3 more
doaj   +1 more source

The contribution of caregiver psychosocial factors to distress associated with behavioural and psychological symptoms in dementia [PDF]

, 2016
Copyright © 2016 John Wiley & Sons, Ltd. Objective: The objective of the study is to examine caregiver factors as predictors of BPSD-related distress and their potential mechanisms.
Ablitt, American Psychiatric Association, Ankri, Arbuckle, Bandeira, Baron, Bentler, Bentler, Bird, Campbell, Chan, Cheng, Craig, Crellin, Cummings, Cummings, EuroQoL Group, Fauth, Franche, Gaugler, Gonyea, Greene, Holmbeck, IBM Corp., Iecovich, Jackson, Jarrett, Kline, Kline, Knight, Lee, Lenior, Lyonette, Melo, Miranda-Castillo, Ngai, Orgeta, Ornstein, Pearlin, Powers, Preacher, Quinn, Reisberg, Roach, Schreiber, Siegert, Sobel, Springate, Spruyette, Steadman, Steiger, Tan, Teri, Townsend, Vernooij-Dassen, Vernooij-Dassen, Vugt, Wells, Williamson, Zarit   +59 more
core   +2 more sources

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub, Michele K. York, Roseanne Dobkin, Anuprita R. Nair, Ryan Kurth, David‐Erick Lafontant, Chelsea Caspell‐Garcia, Roy N. Alcalay, Ethan G. Brown, Lana M. Chahine, Christopher Coffey, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kenneth Marek, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, Andrew Siderowf, Cristina Simonet, Tanya Simuni, Caroline M. Tanner, Thomas F. Tropea, Aleksandar Videnovic, The Parkinson's Progression Markers Initiative   +24 more
wiley   +1 more source